Farmacosmo SpA (MIL:COSMO) Research & Development: €0.00 Mil (TTM As of Dec. 2025)


MIL:COSMO Farmacosmo SpA MIL:COSMO
33 GF Score
Price €0.50
GF Value €0.73
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Farmacosmo SpA Research & Development?

Farmacosmo SpA MIL:COSMO -0.79% 33 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates MIL:COSMO with a GF Score™ of 33/100 and a GF Value™ of €0.73 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Farmacosmo SpA's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Farmacosmo SpA  (MIL:COSMO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Farmacosmo SpA Research & Development Related Terms

Farmacosmo SpA Research & Development Historical Data

* Premium members only.

The historical data trend for Farmacosmo SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmacosmo SpA Research & Development Chart

Farmacosmo SpA Annual Data
Trend Dec19 Dec20 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Farmacosmo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:COSMO
33GF Score
Farmacosmo SpA MIL:COSMO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Farmacosmo SpA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Farmacosmo SpA (MIL:COSMO) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Farmacosmo SpA and its competitors.
Is Farmacosmo SpA's Research & Development too high?
Farmacosmo SpA's current Research & Development is €0.00 Mil. Overall, Farmacosmo SpA has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Farmacosmo SpA's Research & Development compare to competitors?
Farmacosmo SpA's Research & Development of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Farmacosmo SpA and its competitors. Farmacosmo SpA's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmacosmo SpA stock overvalued right now?
Based on GuruFocus' analysis, Farmacosmo SpA (MIL:COSMO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.73, compared to a current price of €0.50 — trading 31.2% below its estimated fair value. The current Research & Development is €0.00 Mil. Farmacosmo SpA's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Farmacosmo SpA (MIL:COSMO), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Farmacosmo SpA (MIL:COSMO) Overvalued in 2026?

Based on GuruFocus' analysis, Farmacosmo SpA stock appears to be undervalued. The current stock price of €0.50 is trading 31.2% below its estimated GF Value™ of €0.73. GuruFocus considers Farmacosmo SpA to be Possible Value Trap.

Key valuation signals for MIL:COSMO:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.73 vs. price of €0.50 (31.2% below fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the MIL:COSMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Farmacosmo SpA Business Description

Address Via Crispi, Number 51, Napoli, ITA, IT-80121
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
33GF Score

Get the complete analysis for MIL:COSMO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price
€0.73
GF Value